Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 9,607Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 12care4 ApS

02 2ANI Pharmaceuticals Inc

03 1Actavis Inc

04 1Apotex Inc

05 1Bio Labs

06 1GSK

07 1Gebro Pharma

08 1Genus Lifesciences

09 1Haleon

10 1Hasco-Lek

11 1NEW HEIGHTSRX

12 5Novartis Pharmaceuticals Corporation

13 1Omnivium Pharmaceuticals

14 1PLD ACQUISITIONS

15 1Paranova Group AS

16 1Perrigo Company plc

17 2Teva Pharmaceutical Industries

18 1Wockhardt

19 5World Medicine

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLEMASTINE FUMARATE

Brand Name : CLEMASTINE FUMARATE

Dosage Form : SYRUP;ORAL

Dosage Strength : EQ 0.5MG BASE/5ML

Packaging :

Approval Date : 1993-10-31

Application Number : 74075

Regulatory Info : DISCN

Registration Country : USA

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLEMASTINE FUMARATE

Brand Name : CLEMASTINE FUMARATE

Dosage Form : TABLET;ORAL

Dosage Strength : 1.34MG

Packaging :

Approval Date : 1992-01-31

Application Number : 73282

Regulatory Info : DISCN

Registration Country : USA

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLEMASTINE FUMARATE

Brand Name : CLEMASTINE FUMARATE

Dosage Form : TABLET;ORAL

Dosage Strength : 1.34MG

Packaging :

Approval Date : 1992-12-03

Application Number : 73282

Regulatory Info : DISCN

Registration Country : USA

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLEMASTINE FUMARATE

Brand Name : CLEMASTINE FUMARATE

Dosage Form : SYRUP;ORAL

Dosage Strength : EQ 0.5MG BASE/5ML

Packaging :

Approval Date : 2000-11-27

Application Number : 75703

Regulatory Info : DISCN

Registration Country : USA

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLEMASTINE FUMARATE

Brand Name : CLEMASTINE FUMARATE

Dosage Form : SYRUP;ORAL

Dosage Strength : EQ 0.5MG BASE/5ML

Packaging :

Approval Date : 1994-06-30

Application Number : 73399

Regulatory Info : RX

Registration Country : USA

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLEMASTINE FUMARATE

Brand Name : TAVIST-1

Dosage Form : TABLET;ORAL

Dosage Strength : 1.34MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1992-08-21

Application Number : 20925

Regulatory Info : DISCN

Registration Country : USA

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLEMASTINE FUMARATE

Brand Name : TAVIST

Dosage Form : TABLET;ORAL

Dosage Strength : 2.68MG

Packaging :

Approval Date : 1982-01-01

Application Number : 17661

Regulatory Info : DISCN

Registration Country : USA

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLEMASTINE FUMARATE

Brand Name : TAVIST-1

Dosage Form : TABLET;ORAL

Dosage Strength : 1.34MG

Packaging :

Approval Date : 1982-01-01

Application Number : 17661

Regulatory Info : DISCN

Registration Country : USA

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLEMASTINE FUMARATE

Brand Name : TAVIST-1

Dosage Form : TABLET;ORAL

Dosage Strength : 1.34MG

Packaging :

Approval Date : 1992-08-21

Application Number : 17661

Regulatory Info : DISCN

Registration Country : USA

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLEMASTINE FUMARATE

Brand Name : TAVIST

Dosage Form : SYRUP;ORAL

Dosage Strength : EQ 0.5MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1985-06-28

Application Number : 18675

Regulatory Info : DISCN

Registration Country : USA

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ACETAMINOPHEN; CLEMASTINE FUMARATE; PSEUDOEPHEDRINE HYDROCHLORIDE

Brand Name : TAVIST ALLERGY/SINUS/HEADACHE

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG;EQ 0.25MG BASE;30MG

Packaging :

Approval Date : 2001-03-01

Application Number : 21082

Regulatory Info : DISCN

Registration Country : USA

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLEMASTINE FUMARATE

Brand Name : CLEMASTINE FUMARATE

Dosage Form : TABLET;ORAL

Dosage Strength : 2.68MG

Packaging :

Approval Date : 1993-10-31

Application Number : 73459

Regulatory Info : DISCN

Registration Country : USA

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLEMASTINE FUMARATE

Brand Name : CLEMASTINE FUMARATE

Dosage Form : TABLET;ORAL

Dosage Strength : 1.34MG

Packaging :

Approval Date : 1995-11-22

Application Number : 74512

Regulatory Info : DISCN

Registration Country : USA

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLEMASTINE FUMARATE

Brand Name : CLEMASTINE FUMARATE

Dosage Form : TABLET;ORAL

Dosage Strength : 1.34MG

Packaging :

Approval Date : 1993-10-31

Application Number : 73458

Regulatory Info : DISCN

Registration Country : USA

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLEMASTINE FUMARATE

Brand Name : CLEMASTINE FUMARATE

Dosage Form : SYRUP;ORAL

Dosage Strength : EQ 0.5MG BASE/5ML

Packaging :

Approval Date : 1992-04-21

Application Number : 73095

Regulatory Info : DISCN

Registration Country : USA

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLEMASTINE FUMARATE

Brand Name : CLEMASTINE FUMARATE

Dosage Form : TABLET;ORAL

Dosage Strength : 2.68MG

Packaging :

Approval Date : 1992-01-31

Application Number : 73283

Regulatory Info : RX

Registration Country : USA

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLEMASTINE FUMARATE

Brand Name : CLEMASTINE FUMARATE

Dosage Form : SYRUP;ORAL

Dosage Strength : EQ 0.5MG BASE/5ML

Packaging :

Approval Date : 1998-03-13

Application Number : 74863

Regulatory Info : DISCN

Registration Country : USA

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Bisoprolol Fumarate; Clemastine

Brand Name :

Dosage Form : FILM COATED TABLET

Dosage Strength :

Packaging : 30 Tablets

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Turkey

blank

19

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Bisoprolol Fumarate; Clemastine

Brand Name :

Dosage Form : FILM COATED TABLET

Dosage Strength :

Packaging : 30 Tablets

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Turkey

blank

20

NEW HEIGHTSRX

Country
2024 ACI Convention
Not Confirmed
arrow

NEW HEIGHTSRX

Country
arrow
2024 ACI Convention
Not Confirmed

CLEMASTINE FUMARATE

Brand Name : CLEMASTINE FUMARATE

Dosage Form : SYRUP;ORAL

Dosage Strength : EQ 0.5MG BASE/5ML

Packaging :

Approval Date : 1997-12-17

Application Number : 74884

Regulatory Info : RX

Registration Country : USA

blank